All Articles
As 2026 Forges Ahead, A Look Back at HOPA in 2025
2025 certainly brought challenges both new and familiar to HOPA, our members, our patients, and those dear to them. But it's also brought hope. It's brought progress. And it's brought an inspiring sense of purpose, passion, and community.
Proposed Student Loan Limits for Nursing and Other Professions Will Contribute to Healthcare Worker Shortages
HOPA is concerned about the Department of Education's proposed language and student loan limits for professions crucial to oncology care, especially nursing. Implementation will contribute to the shortage of healthcare workers in this country.
Work-Life Harmony Isn’t About Perfection; It’s About Priorities and Support
Striking the balance between work and family is challenging, but with the right mindset and support, it is possible. And when we succeed, we not only become better parents but also better pharmacists, leaders, and colleagues.
The Impacts of Strong Professional Relationships Between Clinical Pharmacists and Medical Science Liaisons
In this piece from the HOPA News archives, authors Megan Langer and Jake Hanlin reflect on how medical science liaisons have impacted their patient care and professional careers - and what tips they have for productively working with them.
Getting Away From the Guilt Trip: Reflections on Balancing Family Life with Our Livelihood
In response to December's episode of the HOPA Now Podcast, HOPA Wellness Advisory Group member Teresa Kam Thakrar contributed the following personal reflection about balancing family with a career in oncology pharmacy.
Late-Breaking HOPA News: Belantamab Mafodotin-bmlf Returns: FDA Restores BCMA-Targeted ADC Option for RRMM
Marshall Winget, PharmD, and Bradley Yelvington, PharmD, BCOP, discuss the recent reapproval of belantamab mafodotin in BCMA-directed therapy for relapsed or refractory multiple myeloma.
Pharmacist's Application to Practice: Obecabtagene autoleucel
Crystal Chung, PharmD, PGY2 Oncology Pharmacy Resident, and Emma Sheldon, PharmD, BCOP, Oncology Pharmacy Specialist - Bone Marrow Transplant/Cellular Therapy, both from Scripps Health in San Diego, CA, discuss obecabtagene autoleucel (Aucatzyl).
Pharmacist's Application to Practice: Dordaviprone
Nghi Nguyen, PharmD, PGY1 Pharmacy Resident, and Andrea Clarke, PharmD, BCOP, Hematology/Cellular Therapy Clinical Pharmacy Specialist - both from Wellstar MCG Health in Augusta, GA - deep dive into the potential role and clinical pearls of dordaviprone.
Pharmacist's Application to Practice: Linvoseltamab-gcpt
Nikki Kalem, PharmD, PGY2 Oncology Pharmacy Resident, at Henry Ford Hospital in Detroit, MI, writes about the recent accelerated approval of linvoseltamab-gcpt for the treatment of relapsed or refractory multiple myeloma in adults.
Late-Breaking HOPA News: The Evolving Landscape of NPM1-Mutated AML
Moh'd Mohanad A. Al-Dabet, PhD, AHI(AMT); Katia Al-Sawalha, BSc; and Olivia White, PharmD, BCOP, review revumenib and ziftomenib for NPM-1m disease and highlight key considerations when implementing these two therapies.
What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown
On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.